Steven Cohen Seres Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.15 $557,163 - $1.29 Million	-599,100 Reduced 21.79%	2,150,000 $3.01 Million
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $4.03 Million - $8.76 Million	1,728,700 Added 169.41%	2,749,100 $6.54 Million
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $3.4 Million - $4.77 Million	727,600 Added 248.5%	1,020,400 $4.89 Million
Q1 2023 May 15, 2023	SELL	$4.95 - $6.09 $2.01 Million - $2.48 Million	-406,800 Reduced 58.15%	292,800 $1.66 Million
Q4 2022 Feb 14, 2023	SELL	$5.09 - $9.05 $1.22 Million - $2.17 Million	-239,829 Reduced 25.53%	699,600 $3.92 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $2.12 Million - $4.35 Million	604,429 Added 180.43%	939,429 $6.03 Million
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $904,500 - $2.55 Million	335,000 New	335,000 $1.15 Million
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $18 Million - $23.7 Million	-974,671 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $15.4 Million - $25.1 Million	869,225 Added 824.33%	974,671 $20.1 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $1.42 Million - $2.3 Million	-60,942 Reduced 36.63%	105,446 $2.58 Million
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $622,291 - $4.78 Million	166,388 New	166,388 $4.71 Million

46.7M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.